NIche Development With Closure of Cesarean Uterotomy by Modified or

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06466343` - Immunohistopathologic Findings of Cesarean Scar Niche	N/A
Completed	`NCT03257514` - Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section	Phase 2
Completed	`NCT03609281` - Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries
Recruiting	`NCT05777837` - Laparoscopic Versus Combined Laparoscopic and Hysteroscopic Repair of CS Niche	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT06466343 - Immunohistopathologic Findings of Cesarean Scar Niche

N/A

Completed

NCT03257514 - Effect of Alpha Lipoic Acid on Uterine Scar Healing After Cesarean Section

Phase 2

Completed

NCT03609281 - Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries

Recruiting

NCT05777837 - Laparoscopic Versus Combined Laparoscopic and Hysteroscopic Repair of CS Niche

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02410395
Study type	Interventional
Source	University of Aarhus
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 1, 2015
Completion date	March 2023

NIche Development With Closure of Cesarean Uterotomy by Modified or Conventional Two-layer Technique — NICUM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms